A Study to Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment
Clinical trial NCT05473715 · TERMINATED
Trial details
- NCT number
- NCT05473715
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2023-07-11
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.